ArticleFrontiers in endocrinology2025
Analysis and prediction of serological indicators associated with colorectal interval polyposis after resection.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The examination of the endoscope and the subsequent rediscovery of polyps after endoscopic intervention presents a significant clinical challenge. Multiple factors may contribute to this phenomenon. This study aimed to identify determinants of interval polyposis by analyzing common serological markers and polyp-related variables, ultimately developing a predictive model. Methods: This retrospective study included 415 patients diagnosed with colorectal polyps who underwent either endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) at Chaohu Hospital affiliated with Anhui Medical University between December 1, 2022 and December 31, 2023. The primary objective was to evaluate associations between hematologic indicators, polyp-related characteristics, and the risk of rediscovery colorectal polyps. Interval polyposis was defined as the detection of one or more polyps within 18 months after the initial polypectomy, regardless of anatomical location. Follow-up data were obtained through electronic medical records, including demographic information (age, sex, smoking and alcohol use, hypertension, and diabetes history), anthropometric measures (weight, height, BMI), surgical details, polyp features (location, size, number, histological type), and relevant serological parameters. Results: Significant differences were observed between the non-interval polyposis and interval polyposis groups in terms of hypertension, diabetes, triglycerides (TG) and the number of polyps (P < 0.05). Binary logistic regression analysis identified four independent risk factors: hypertension (OR, 2.741; 95% CI, 1.451-5.179), diabetes (OR, 4.828; 95% CI, 1.943-11.995), number of polyps (OR, 1.211; 95% CI, 1.078-1.361) and triglyceride levels (OR, 1.823; 95% CI, 1.303-2.551). Conclusion: Hypertension, diabetes, an increased number of polyps and elevated triglyceride levels are independent predictors of colorectal interval polyposis following endoscopic resection. These findings underscore the importance of monitoring blood pressure, blood sugar, triglyceride levels and conducting regular colonoscopic surveillance in high-risk individuals to facilitate early detection and management of interval polyposis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.